Getting study teams to consider using readily available data to help design and enroll clinical trials can be more difficult than it should be. Read More
Multi-page feasibility questionnaires are high on sites’ list of experiences they’d rather avoid, but is there a better way to provide sponsors with the information they need? Read More
We’ve all heard the stories of deliberate data fraud in clinical trials: the investigator who created fictional subjects, the lab technician who duplicated test data, the coordinator who altered records. What makes people think they can get away with it? Read More
Multi-page feasibility questionnaires are high on sites’ list of experiences they’d rather avoid, but is there a better way to provide sponsors with the information they need? Read More
We’ve all heard the stories of deliberate data fraud in clinical trials: the investigator who created fictional subjects, the lab technician who duplicated test data, the coordinator who altered records. What makes people think they can get away with it? Read More
The following summary of CenterWatch’s 2019 Global Site Relationship Survey presents sites’ views on the sponsors they work with. The December issue of The CenterWatch Monthly will report sites’ opinions on CROs.
Sponsors’ ability to meet the needs of their sites has improved slightly in recent years, according to a new CenterWatch survey, but sites say they need to see more progress in almost all aspects of their working relationship.
Quality principles should be incorporated into clinical trial design from the beginning, says one pharma executive, to save time and money and avoid disasters that could cripple a trial. Read More
The clinical trials industry is divided on the value of virtual trials, with some thought leaders extolling their benefits and others decrying the loss of personal contact between patient and trial.
Relying on digital solutions for data-gathering and communication, sponsors and research organizations can reach patients that might otherwise not be able to participate and can save money by cutting the trial site out of the equation.